Panama's HPV Vaccine Reaches 85% as Cancer Cases Drop

Panama is proving that ambitious vaccination programs can deliver real results in the fight against cervical cancer.

The country made history as the first in Latin America to include the HPV vaccine in its national immunization program. Now, researchers at the University of South Florida have documented the success: vaccination rates regularly top 85 percent, and cervical cancer cases have been declining steadily since the 1990s.

Dr. Arlene Calvo, who led the research at USF's College of Public Health, says the findings offer a roadmap for other countries working to eliminate the disease. Her team analyzed decades of national health data from Panama to understand how vaccination, screening, and healthcare access work together to prevent cervical cancer.

The success is especially meaningful in Latin America, where cervical cancer remains the second leading cause of cancer deaths among women. Panama's willingness to invest early in prevention is now paying off for thousands of women and families.

But the research also revealed an important challenge. While fewer women are developing cervical cancer, death rates remain higher than expected. Many women only seek medical care after the disease has progressed to advanced stages, when treatment options are limited.

The gap appears to be cultural and practical rather than medical. Only about 10 to 12 percent of women in Panama currently receive regular Pap tests, the screening tool that catches cervical cancer early when it's most treatable.

Dr. Humberto López Castillo, who contributed to the study, sees an opportunity in the contrast. "Health authorities could separate the success elements in the vaccination campaigns and adapt them to further support campaigns supporting Pap smears," he said.

The Ripple Effect

The research is already inspiring medical students and public health professionals across the region. Jonathan Andreadakis, who worked on the study as a graduate student, says the global commitment to reducing cervical cancer motivates the next generation of researchers.

Panama's model shows that large scale vaccination programs can work even in countries with limited resources. Other Latin American nations are now watching closely to learn from both the successes and the remaining challenges.

The findings give health officials concrete data to expand prevention strategies and improve access to screening services. Calvo hopes policymakers will use the research to develop programs that support women throughout their healthcare journey, from vaccination in childhood through regular screening in adulthood.

What started as one country's bold decision to prioritize prevention is becoming a success story with lessons for the entire region.